HUTCHMED (China) (HMDCF) Return on Invested Capital (2018 - 2021)

HUTCHMED (China) (HMDCF) reported Return on Invested Capital of 0.01% for Q4 2021, down 33.47% quarter-over-quarter from 0.01% in Q2 2021.

HUTCHMED (China) (HMDCF) Return on Invested Capital (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2021.

  • Return on Invested Capital for Q4 2021 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.22%, up 22.0% from the prior year.
  • Return on Invested Capital slipped to 0.01% in Q4 2021 per HMDCF's latest filing, from 0.01% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.01% in Q1 2021 and troughed at 0.2% in Q2 2019.
  • A 3-year average of 0.03% and a median of 0.0% in 2019 frame the typical range for Return on Invested Capital.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 0.00%
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 0.01%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 0.00%
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 0.00%
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn 0.00%
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 0.00%
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 0.00%
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 0.00%
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn -
10 HUTCHMED (China) - - - -

Historic Data

Download Data
DateValue
Dec 31, 2021 0.01%
Jun 30, 2021 0.01%
Mar 31, 2021 0.01%
Jun 30, 2019 -0.20%
Mar 31, 2019 0.00%
Dec 31, 2018 0.00%